6/6/2025Beigene's BGB‑16673 Enters Phase 1b Trial for Chronic Urticaria in Ch...

6/6/2025Qilu Launches Phase III Trial of QL1706 + Bevacizumab

6/6/2025BMS's Reblozyl Approved in China for Lower‑Risk MDS‑Related Anemia

6/6/2025AstraZeneca's Imfinzi Approved in China for LS‑SCLC

6/6/2025Keymed Launches First-in-Human Trial of CM518D1

6/6/2025AbbVie's Rinvoq (Upadacitinib) Gains Approval in China for Giant Cell ...

6/6/2025Kelun‑Biotech Initiates Phase II Trial of PTK7‑Targeted ADC SKB518 i...

6/6/2025Akeso's Cadonilimab Gains First-Line Approval in Cervical Cancer in Ch...

6/5/2025CSPC Receives Chinese Approval for Cobamamide Capsules to Treat Anemia

6/5/2025Cullinan Secures Global Rights to Genrix's Velinotamig

6/5/2025NHSA Issues Notice to Enhance Drug Pricing and Procurement Credit Eval...

6/5/2025Ascletis's Denifanstat Shows Promising Results in Phase III Acne Trial

6/4/2025Biocytogen and CTTQ Receive IND Approval in China for Next-Gen Anti-IG...

6/4/2025China Approves First Homegrown 9-Valent HPV Vaccine

6/4/2025Sagimet and Ascletis Report Positive Phase 3 Results for Denifanstat i...

6/4/2025China's Child Health Improves: NHC Official

6/3/2025BioAge Partners with JiKang Thera for APJ Agonist After Obesity Drug S...

6/3/2025Akeso Stumbles as FDA Sets Higher Bar for Ivonescimab Approval

6/3/2025Leads Biolabs' LBL-024 Shows Promising Results in EP-NEC Treatment

6/3/2025Remegen, Junshi Report Strong DV Combo Data in HER2+ Gastric Cancer

6/3/2025CTTQ Achieves Breakthrough in Lung Cancer Treatment

6/3/2025Transcenta's Triple Therapy Shows Promising Results for G/GEJ

6/3/2025Innovent's IBI343 Shows Promise in Advanced Pancreatic Cancer

6/3/2025LongBio Secures Over CNY 200M in Series C Financing

6/3/2025Neowise Licenses TCR Candidate to BeiGene for Off-the-Shelf Cell Thera...

6/3/2025Hanx Biopharma Files for Hong Kong IPO to Advance Innovative Cancer Th...

6/2/2025Mabwell's Mailisheng Injection Gains Chinese Approval for Chemotherapy...

6/2/2025BioNTech's China-Origin Immunotherapy at Center of $11.1B Deal with BM...

6/2/2025Regeneron Licenses Hansoh's Dual GLP-1/GIP Receptor Agonist to Bolster...

6/2/2025OnCusp Unveils Promising Initial Results from First-in-Human Trial of ...

Page:14/56 Total number of articles:1675: [First][<<] [12] [13] [14] [15] [16] [>>] [End]